These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 15470596)
1. Antibody World Summit 2004-SRI Conference 19-21 July 2004, Philadelphia, PA, USA. Nock S IDrugs; 2004 Sep; 7(9):825-8. PubMed ID: 15470596 [TBL] [Abstract][Full Text] [Related]
2. Metabolic Diseases Drug Discovery World Summit--SRI conference. 28-29 July 2003 San Diego, CA, USA. Knittel T IDrugs; 2003 Sep; 6(9):845-9. PubMed ID: 14565169 [No Abstract] [Full Text] [Related]
3. Antibody World Summit 2007--SRI's Sixth Annual Meeting. Discovery & development/manufacturing & processing. 16-17 July 2007, New Brunswick, NJ, USA. Morrow KJ IDrugs; 2007 Oct; 10(10):686-9. PubMed ID: 17899482 [No Abstract] [Full Text] [Related]
4. Metabolic Diseases Drug Discovery World Summit--SRI conference. Diabetes and obesity. 28-29 July 2003 San Diego, CA, USA. Xu J IDrugs; 2003 Sep; 6(9):850-1. PubMed ID: 14565170 [No Abstract] [Full Text] [Related]
5. International Drug Discovery Science and Technology--BIT's Seventh Annual Congress. Bodovitz S IDrugs; 2010 Jan; 13(1):23-5. PubMed ID: 20024843 [TBL] [Abstract][Full Text] [Related]
6. American Society for Virology-23rd annual meeting. Vaccines and antiviral agents 10-14 July 2004, Montreal Canada. Barnard DL IDrugs; 2004 Sep; 7(9):822-4. PubMed ID: 15470595 [No Abstract] [Full Text] [Related]
7. BioAsia Licensing and Deal-Making Summit-SRI Conference. Life science partnering and investment on the Pacific Rim 2-3 August, 2004, Coronado, CA, USA. Xu J IDrugs; 2004 Sep; 7(9):841-5. PubMed ID: 15470601 [TBL] [Abstract][Full Text] [Related]
11. Drug Development India--CHI's Second Annual Conference. Planning and Managing Drug Discovery & Development Activities. 15-16 November 2007, Philadelphia, PA, USA. Lovretin P; Krishnan A IDrugs; 2008 Feb; 11(2):108-10. PubMed ID: 18240095 [No Abstract] [Full Text] [Related]
12. Strategic Research Institute--first international siRNA conference. Prospect for new therapeutics and commercial opportunities for pharma and biotech. 24-25 March 2003, LaJolla, CA, USA. Xu J IDrugs; 2003 May; 6(5):449-50. PubMed ID: 12841209 [TBL] [Abstract][Full Text] [Related]
13. Influenza Research & Development - GTCBio's Third Annual Conference (July 9-11 - Boston, Massachusetts, USA, 2014). Tompkins SM Drugs Today (Barc); 2014 Aug; 50(8):599-605. PubMed ID: 25187909 [TBL] [Abstract][Full Text] [Related]
14. Characterization and epitope mapping of monoclonal antibodies to the nucleocapsid protein of severe acute respiratory syndrome coronavirus. Kariwa H; Noda H; Nakauchi M; Ishizuka M; Hashiguchi K; Hashimoto S; Yoshii K; Asano A; Agui T; Kogaki H; Kurano Y; Uchida Y; Fujii N; Okada M; Takashima I Jpn J Vet Res; 2008 Feb; 55(4):115-27. PubMed ID: 18380153 [TBL] [Abstract][Full Text] [Related]
15. Characterization of germline antibody libraries from human umbilical cord blood and selection of monoclonal antibodies to viral envelope glycoproteins: Implications for mechanisms of immune evasion and design of vaccine immunogens. Chen W; Streaker ED; Russ DE; Feng Y; Prabakaran P; Dimitrov DS Biochem Biophys Res Commun; 2012 Jan; 417(4):1164-9. PubMed ID: 22226962 [TBL] [Abstract][Full Text] [Related]
16. Metabolic Diseases Drug Discovery-Strategic Research Institute's Third International World Summit. PPAR and PTB1B modulators 26-27 July 2004, San Diego, CA, USA. Xu J IDrugs; 2004 Sep; 7(9):836-8. PubMed ID: 15470599 [No Abstract] [Full Text] [Related]
17. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Pinto D; Park YJ; Beltramello M; Walls AC; Tortorici MA; Bianchi S; Jaconi S; Culap K; Zatta F; De Marco A; Peter A; Guarino B; Spreafico R; Cameroni E; Case JB; Chen RE; Havenar-Daughton C; Snell G; Telenti A; Virgin HW; Lanzavecchia A; Diamond MS; Fink K; Veesler D; Corti D Nature; 2020 Jul; 583(7815):290-295. PubMed ID: 32422645 [TBL] [Abstract][Full Text] [Related]
18. Human monoclonal antibodies as candidate therapeutics against emerging viruses and HIV-1. Zhu Z; Prabakaran P; Chen W; Broder CC; Gong R; Dimitrov DS Virol Sin; 2013 Apr; 28(2):71-80. PubMed ID: 23575729 [TBL] [Abstract][Full Text] [Related]
19. Targeting N-glycan cryptic sugar moieties for broad-spectrum virus neutralization: progress in identifying conserved molecular targets in viruses of distinct phylogenetic origins. Wang D; Tang J; Tang J; Wang LX Molecules; 2015 Mar; 20(3):4610-22. PubMed ID: 25774492 [TBL] [Abstract][Full Text] [Related]
20. Protein phosphorylation drug discovery summit--SRI conference. Targeting kinases and phosphatases for novel therapeutics. 3-5 March 2003, San Diego, CA, USA. Stokoe D IDrugs; 2003 May; 6(5):432-6. PubMed ID: 12841205 [No Abstract] [Full Text] [Related] [Next] [New Search]